Poland
· Delayed Price · Currency is PLN Hemp & Health Statistics
Total Valuation
Hemp & Health has a market cap or net worth of PLN 26.84 million. The enterprise value is 24.26 million.
| Market Cap | 26.84M |
| Enterprise Value | 24.26M |
Important Dates
The next estimated earnings date is Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Hemp & Health has 77.23 million shares outstanding. The number of shares has increased by 6.79% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 77.23M |
| Shares Change (YoY) | +6.79% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 12.31% |
| Owned by Institutions (%) | n/a |
| Float | 64.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 209.34 |
| PB Ratio | 7.13 |
| P/TBV Ratio | 7.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -21.66 |
| EV / Sales | 189.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.55 |
Financial Position
The company has a current ratio of 15.31
| Current Ratio | 15.31 |
| Quick Ratio | 14.91 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -30.90% and return on invested capital (ROIC) is -18.81%.
| Return on Equity (ROE) | -30.90% |
| Return on Assets (ROA) | -18.27% |
| Return on Invested Capital (ROIC) | -18.81% |
| Return on Capital Employed (ROCE) | -28.98% |
| Revenue Per Employee | 42,732 |
| Profits Per Employee | -373,208 |
| Employee Count | 3 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 3.53 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.45% in the last 52 weeks. The beta is -1.29, so Hemp & Health's price volatility has been lower than the market average.
| Beta (5Y) | -1.29 |
| 52-Week Price Change | -33.45% |
| 50-Day Moving Average | 0.35 |
| 200-Day Moving Average | 0.36 |
| Relative Strength Index (RSI) | 43.52 |
| Average Volume (20 Days) | 312,800 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hemp & Health had revenue of PLN 128,196 and -1.12 million in losses. Loss per share was -0.01.
| Revenue | 128,196 |
| Gross Profit | -152,209 |
| Operating Income | -1.09M |
| Pretax Income | -1.12M |
| Net Income | -1.12M |
| EBITDA | -1.03M |
| EBIT | -1.09M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 2.58 million in cash and n/a in debt, giving a net cash position of 2.58 million or 0.03 per share.
| Cash & Cash Equivalents | 2.58M |
| Total Debt | n/a |
| Net Cash | 2.58M |
| Net Cash Per Share | 0.03 |
| Equity (Book Value) | 3.76M |
| Book Value Per Share | 0.05 |
| Working Capital | 2.56M |
Cash Flow
In the last 12 months, operating cash flow was -1.05 million and capital expenditures -740,902, giving a free cash flow of -1.79 million.
| Operating Cash Flow | -1.05M |
| Capital Expenditures | -740,902 |
| Free Cash Flow | -1.79M |
| FCF Per Share | -0.02 |
Margins
| Gross Margin | -118.73% |
| Operating Margin | -850.80% |
| Pretax Margin | -873.37% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Hemp & Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.79% |
| Shareholder Yield | -6.79% |
| Earnings Yield | -4.17% |
| FCF Yield | -6.67% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Hemp & Health has an Altman Z-Score of 98.99.
| Altman Z-Score | 98.99 |
| Piotroski F-Score | n/a |